Low admission LDL-cholesterol is associated with increased 3-year all-cause mortality in patients with non ST segment...

Area of Science:

• Cardiology
• Clinical Lipidology
• Acute Coronary Syndromes

Background:

• The prognostic significance of admission low-density lipoprotein (LDL) levels in acute coronary syndrome (ACS) patients remains unclear.
• This study investigated the hypothesis that patients experiencing non-ST segment elevation myocardial infarction (NSTEMI) with low LDL levels have poorer long-term cardiovascular outcomes.

Purpose of the Study:

• To evaluate the association between admission LDL cholesterol levels and 3-year all-cause mortality in patients with NSTEMI.
• To determine if lower LDL levels predict worse outcomes in this patient population.

Main Methods:

• Retrospective analysis of 517 NSTEMI patients admitted between 1997 and 2000 with fasting lipid profiles within 24 hours.
• Comparison of baseline characteristics and 3-year all-cause mortality between patients with LDL below and above the median (105 mg/dL).
• Multivariate analysis and Cox proportional hazard modeling to identify predictors of mortality and analyze adjusted survival.

Main Results:

• Patients with admission LDL ≤ 105 mg/dL (n=264) exhibited a significantly higher 3-year all-cause mortality rate compared to those with LDL > 105 mg/dL (n=253) (14.8% vs. 7.1%, p=0.005).
• This increased mortality risk persisted after adjusting for confounding variables (OR 1.8, 95% CI 1.0-3.5, p=0.05).
• No significant differences in age, gender, coronary artery disease severity, or left ventricular ejection fraction were observed between the groups.

Conclusions:

• Lower admission LDL-cholesterol levels were associated with decreased 3-year survival in the studied NSTEMI cohort.
• Further research is required to ascertain if this association is due to current therapeutic interventions or reflects underlying worse patient characteristics.